Alice L J Carr

Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

B. Shields, A. Hattersley, M. Nyirenda, 2022, BMJ Open Diabetes Research & Care.

Measurement of Peak C-Peptide at Diagnosis Informs Glycemic Control but not Hypoglycemia in Adults With Type 1 Diabetes

R. Oram, T. Mcdonald, P. Narendran, 2021, Journal of the Endocrine Society.